These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Melanoma brain metastasis presentation, treatment, and outcomes in the age of targeted and immunotherapies. Bander ED; Yuan M; Carnevale JA; Reiner AS; Panageas KS; Postow MA; Tabar V; Moss NS Cancer; 2021 Jun; 127(12):2062-2073. PubMed ID: 33651913 [TBL] [Abstract][Full Text] [Related]
3. Melanoma brain metastases: an unmet challenge in the era of active therapy. Gorantla V; Kirkwood JM; Tawbi HA Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973 [TBL] [Abstract][Full Text] [Related]
4. Advances in the systemic treatment of melanoma brain metastases. Glitza Oliva IC; Schvartsman G; Tawbi H Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899 [TBL] [Abstract][Full Text] [Related]
7. The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: A systematic review. van Opijnen MP; Dirven L; Coremans IEM; Taphoorn MJB; Kapiteijn EHW Int J Cancer; 2020 Mar; 146(6):1479-1489. PubMed ID: 31583684 [TBL] [Abstract][Full Text] [Related]
8. Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study. Gatterbauer B; Hirschmann D; Eberherr N; Untersteiner H; Cho A; Shaltout A; Göbl P; Fitschek F; Dorfer C; Wolfsberger S; Kasprian G; Höller C; Frischer JM Cancer Med; 2020 Jun; 9(11):4026-4036. PubMed ID: 32249551 [TBL] [Abstract][Full Text] [Related]
9. The Treatment of Melanoma Brain Metastases. Kibbi N; Kluger H Curr Oncol Rep; 2016 Dec; 18(12):73. PubMed ID: 27822695 [TBL] [Abstract][Full Text] [Related]
10. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti-PD-1 in patients with metastatic melanoma. Schvartsman G; Ma J; Bassett RL; Haydu LE; Amaria RN; Hwu P; Wong MK; Hwu WJ; Diab A; Patel SP; Davies MA; Hamerschlak N; Tawbi HA; Glitza Oliva IC Cancer; 2019 Dec; 125(23):4193-4202. PubMed ID: 31398264 [TBL] [Abstract][Full Text] [Related]
11. The role of systemic therapy in melanoma brain metastases: a narrative review. Saleem K; Davar D Chin Clin Oncol; 2022 Jun; 11(3):24. PubMed ID: 35818856 [TBL] [Abstract][Full Text] [Related]
12. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases. Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049 [TBL] [Abstract][Full Text] [Related]
13. Current and emerging options for patients with melanoma brain metastases. Kreidieh FY; Tawbi HA Clin Adv Hematol Oncol; 2022 Oct; 20(10):619-627. PubMed ID: 36206074 [TBL] [Abstract][Full Text] [Related]
14. New Era in the Management of Melanoma Brain Metastases. Tawbi HA; Boutros C; Kok D; Robert C; McArthur G Am Soc Clin Oncol Educ Book; 2018 May; 38():741-750. PubMed ID: 30231345 [TBL] [Abstract][Full Text] [Related]
15. Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities? Gampa G; Vaidhyanathan S; Sarkaria JN; Elmquist WF Pharmacol Res; 2017 Sep; 123():10-25. PubMed ID: 28634084 [TBL] [Abstract][Full Text] [Related]
16. Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockade. Milsch L; Gesierich A; Kreft S; Livingstone E; Zimmer L; Goebeler M; Schadendorf D; Schilling B Eur J Cancer; 2018 Aug; 99():58-65. PubMed ID: 29906735 [TBL] [Abstract][Full Text] [Related]
17. Local and Systemic Management Options for Melanoma Brain Metastases. Amouzegar A; Tawbi HA Cancer J; 2024 Mar-Apr 01; 30(2):102-107. PubMed ID: 38527263 [TBL] [Abstract][Full Text] [Related]
18. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Amaral T; Kiecker F; Schaefer S; Stege H; Kaehler K; Terheyden P; Gesierich A; Gutzmer R; Haferkamp S; Uttikal J; Berking C; Rafei-Shamsabadi D; Reinhardt L; Meier F; Karoglan A; Posch C; Gambichler T; Pfoehler C; Thoms K; Tietze J; Debus D; Herbst R; Emmert S; Loquai C; Hassel JC; Meiss F; Tueting T; Heinrich V; Eigentler T; Garbe C; Zimmer L; J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221017 [TBL] [Abstract][Full Text] [Related]